Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-049277
Filing Date
2024-04-26
Accepted
2024-04-26 17:00:21
Documents
13
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A eldn-20231231.htm   iXBRL 10-K/A 833599
2 EX-31.3 eldn-ex31_3.htm EX-31.3 6452
3 EX-31.4 eldn-ex31_4.htm EX-31.4 6557
  Complete submission text file 0000950170-24-049277.txt   2792371

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20231231.xsd EX-101.SCH 1279307
16 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20231231_htm.xml XML 10577
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36620 | Film No.: 24884939
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)